GSK Is Not Aventis’ “White Knight”; 2004 Will Be A Transition Year
Executive Summary
GlaxoSmithKline will not make a "white knight" bid for Aventis, GSK said during its Feb. 12 year-end earnings presentation
You may also be interested in...
Novartis Misses Out On Another Merger, But Forces Sanofi To Pay More
Novartis will need to start over in its search for a merger partner after bowing out of the bidding process for Aventis
Novartis Misses Out On Another Merger, But Forces Sanofi To Pay More
Novartis will need to start over in its search for a merger partner after bowing out of the bidding process for Aventis
Biovail To Complete Sales Force Reorganization In April, Adds Specialty Reps
Biovail will complete the reorganization of its sales force, including the addition of two specialty forces, in April, Senior VP-Commercial Operations Kris Peterson said